Alobresib is an antineoplastic drug candidate.
For research use only. We do not sell to patients.
Name | Alobresib |
---|---|
Iupac Chemical Name | [2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)- 1H-benzimidazol-4-yl]di(pyridin-2-yl)methanol |
Synonyms | Alobresib |
Molecular Formula | C26H23N5O2 |
Molecular Weight | 437.5 |
Smile | OC(C1=NC=CC=C1)(C2=C3N=C(C4CC4)NC3=CC(C5=C(C)ON=C5C)=C2)C6=NC=CC=C6 |
InChiKey | CMSUJGUHYXQSOK-UHFFFAOYSA-N |
InChi | InChI=1S/C26H23N5O2/c1-15-23(16(2)33-31-15)18-13-19(24-20(14-18)29-25(30-24)17-9-10-17)26(32,21-7-3-5-11-27-21)22-8-4-6-12-28-22/h3-8,11-14,17,32H,9-10H2,1-2H3,(H,29,30) |
CAS Number | 1637771-14-2 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | >98% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |